Список литературы

1. Thin RN, Symonds MAE, Booker R, Cook S, Langlet F. Double-blind comparison of a single dose and a fiveday course of metronidazole in the treatment of trichomoniasis. Brit J Vener Dis 1979; 55: 354 - 356

2. Forna F, Gulmezoglu AM. Interventions for treating trichomoniasis in women (Cochrane Review). In: The Cochrane Library, Issue 3, 2000. Oxford: Update Software.

3. Hager D, Brown ST, Kraus SJ, Kleris GS, Perkins GJ, Henderson M, Perkins GJ, Henderson M. Metronidazole for vaginal trichomoniasis seven day vs single-dose regimens. JAMA 1980; 244: 1219 - 1220

4. Das S, Huegnsberg M, Shahmanesh M. Treatment failure of vaginal trichomoniais in clinical practice. Intl J STD & AIDS 2005; 16: 284 - 286

5. Hager D, Brown ST, Kraus SJ, Kleris GS, Perkins GJ, Henderson M, Perkins GJ, Henderson M. Metronidazole for vaginal trichomoniasis seven day vs single-dose regimens. JAMA 1980; 244: 1219 - 1220

6. Thin RN, Symonds MAE, Booker R, Cook S, Langlet F. Double-blind comparison of a single dose and a five-day course of metronidazole in the treatment of trichomoniasis. Brit J Vener Dis 1979; 55: 354

7. M Skold, H Gnarpe, and L Hillstrom Ornidazole: a new antiprotozoal compound for treatment of Trichomonas vaginalis infection Br J Vener Dis. 1977 Feb; 53(1): 44 - 48.

8. Lyng J, Christensen J. A double blind study of treatment with a single dose tinidazole of partners to females with trichomoniasis. Acta Obstet Gynecol Scand 1981; 60: 199 - 201

9. Chaisilwattana P, Bhiraleus P, Patanaparnich P, Bhadrakom C. Double blind comparative study of tinidazole and ornidazole as a single dose treatment of vaginal trichomoniasis. J Med Assoc Thai. 1980 Aug; 63(8): 448 - 53.

10. Dykers JR. Single dose metronidazole treatment for trichomonal vaginitis - patient and consort. N Eng J Med 1975; 293; 23 - 24

11. Spence MR, Harwell TS, Davies MC, et al. The minimum single oral metronidazole dose for treating trichomoniasis: a randomized, blinded study. Obstet Gynecol 1997; 89(5 Pt 1): 699 - 703.

12. Prasertsawat PO, Jetsawangsri T. Split-dose metronidazole or single-dose tinidazole for the treatment of vaginal trichomoniasis. Sex Transm Dis 1992; 19: 295 - 7.

13. Fugere P, Verschelden G, Caron M. Single oral dose of ornidazole in women with vaginal trichomoniasis. Obstet Gynecol. 1983 Oct; 62(4): 502 - 5.

14. Serup J, Jensen RH Treatment of trichomoniasis vaginalis with single oral dosage of ornidazole (Tiberal) and tinidazole (Fasigyn). A controlled study. Ugeskr Laeger. 1978 Jun 19; 140(25): 1483 - 4.

15. Федеральные клинические рекомендации. Дерматовенерология 2015: Болезни кожи. Инфекции, передаваемые половым путем. - 5-е изд., перераб. и доп. - М.: Деловой экспресс, 2016. - 768 с.

16. Burtin P, Taddio A, Adburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a metaanalysis. Am J Obstet Gynecol 1995; 172: 525 - 529

17. Caro-Paton T, Carvajal A, de diego IM, Martin-Arias LH, Requejo AA, Pinilla ER. Is metronidazole teratogenic: a meta-analysis. Br J Clin Pharmacol 1997; 44: 179 - 18243.

18. Gulmezoglu AM, Azhar M.Interventions for trichomoniasis in pregnancy//Cochrane Database Syst Rev. 2011 May 11; (5): CD000220. doi: 10.1002/14651858.CD000220.pub2. Review.PMID: 21563127

19. Krashin JW, Koumans EH, Bradshaw-Sydnor AC, Braxton JR, Evan Secor W, Sawyer MK, Markowitz LE.. Trichomonas vaginalis prevalence, incidence, risk factors and antibioticresistance in an adolescent population Sex Transm Dis. 2010 Jul; 37(7): 440 - 4.

20. Sobel JD, Nyirjesy P, Brown W. Tinidazole Therapy for Metronidazole-Resistant Vaginal Trichomoniasis. Clinical Infectious Diseases 2001; 33: 1341 - 1346

21. Adjei C, Boateng R, Dompreh A et al. Prevalence and the evaluation of culture, wet mount, and ELISA methods for the diagnosis of Trichomonas vaginalis infection among Ghanaian women using urine and vaginal specimens. Trop Med Health. 2019 May 16; 47: 33. doi: 10.1186/s41182-019-0162-9. eCollection 2019.

22. Bickley LS, Krisher KK, Punsalang A, Trupei MA, R R eichman RC, Menegus MA. Comparison of direct fluorescent antibody, acridine orange, wet mount and culture for detection of Trichomonas vaginalis in women attending a public sexually transmitted disease clinic. Sex Trans Dis 1989; 127 - 131

23. Kreiger JN, Tam MR, Stevens CE, et al. Diagnosis of trichomoniasis: comparison of conventional wet-mount examination with cytological studies, cultures, and monoclonal antibody staining of direct specimens. JAMA 1988; 259: 1223 - 1227

24. Kreiger JN, Viridans M, Siegel N, Critchlow C, Holmes KK. Risk assessment and laboratory diagnosis of trichomoniasis in men. J Infect Dis 1992; 166: 1362 - 1366

25. Schmid, G.P., Matheny, L.C., Zaidi, A.A. et al. Evaluation of six media for the growth of Trichomonas vaginalis from vaginal secretions. J.Clin.Microbiol 1989; 27: 1230 - 1233.

26. Gelbart, S.M., Thomason, J.L., Osypowski et al. Growth of Trichomonas vaginalis in commercial culture media. J.Clin.Microbiol 1990; 28, 962 - 964.

27. Madico G, Quinn TC, Rompalo A, McKee KT jr, Gaydos CA. Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol 1998; 36: 3205 - 3210

28. Mayta H, Gilman RH, Calderon MM, Gottlieb A, Soto Gtuero I, Sanchez S, Vivar A. 18S ribosomal DNA-based PCR for the diagnosis of Trichomonas vaginalis. J Clin Microbiol 2000; 38: 2683 - 2687

29. Weise W, Patel SC et al. A meta-analysis of the Pap anicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am J Med 2000; 108: 301 - 308

30. Марданлы С.Г., Куляш Г.Ю. Проблемы достоверности и объективной оценки результатов лабораторной диагностики гонореи, трихомониаза и урогенитального хламидиоза: учебно-методическое пособие/С.Г. Марданлы, Г.Ю. Куляш. - Электрогорск: ЗАО "ЭКОлаб", 2011. - 48 с.

31. United Kingdom National Guideline on the Management of Trichomonas vaginalis 2014. Available https://www.bashh.org/documents/UK%20national%20guideline%20on%20the%20management%20of%20TV%20%202014.pdf

32. Renton A, Filatova E, Ison C, Meheus A, Dmitriev G, Akovbian V, et al. A trial of the validity of genital smears and cultures with gonococcal vaccine provocation in diagnosing genital gonorrhoea in women. Int J STD AIDS 2009; 20: 24 - 29.

33. Nye MB, Schwebke JR, Body BA Comparison of APTIMA Trichomonas vaginalis transcription mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women American Journal of Obstetrics and Gynecology, 2009, 200: 188.e181 - 188.e187

34. Hobbs MM et al Methods for detection of Trichomonas vaginalis in the male partners of infected women: implications for control of trichomoniasis. Journal of Clinical Microbiology, 2006, 44: 3994 - 3999

35. Cosentino LA, Campbell T, Jett A et al Use of nucleic acid amplification testing or diagnosis of anorectal sexually transmitted infections J Clin Microbiol 2012; 50: 2005 - 855.

36. Schwebke JR, Hobbs MM, Taylor SN, Sena AC, Catania MG, Weinbaum BS, Johnson AD, Getman DK, Gaydos CA. Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial. J Clin Microbiol. 2011 Dec; 49(12): 4106 - 11.

37. Borchardt KA et al. A comparison of the sensitivity of the InPouch TV, Diamond"s and Trichosel media for detection of Trichomonas vaginalis. Genitourinary Medicine, 1997, 73: 297298.38.

38. el Naga IF, Khalifa AM, el Azzouni MZ. In-pouch TV culture system in diagnosis of Trichomonas vaginalis infection. Journal of the Egyptian Society of Parasitology, 2001, 31: 647656.

39. Das S, Huengsberg M, Shahmanesh M. Treatment failure of vaginal trichomoniasis in clinical practice Int J STD AIDS 2005; 16: 284 - 286.

40. Datta S, Mercer CH, Keeling MJ. et al. Capturing sexual contact patterns in modelling the spread of sexually transmitted infections: Evidence using Natsal-3. PLoS One. 2018 Nov 1; 13(11): e0206501. doi: 10.1371/journal.pone.0206501.

41. Craig-Kuhn MC, Granade C, Muzny CA Optimal Timing for Trichomonas vaginalis Test of Cure Using Nucleic Acid Amplification Testing. Sex Transm Dis. 2019 May; 46(5): 312 - 316.

42. Silver B. J. et al. Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis//Sexually transmitted diseases. - 2014. - T. 41. - N. 6. - C. 369 - 376.

43. Bosserman EA, Helms DJ, Mosure DJ et al Utility of antimicrobial susceptibility testing in Trichomonas vaginalis infected women with clinical treatment failure Sex Transm Dis 2011; 38: 983 - 98.

44. Gaydos CA, Klausner JD, Pai NP et al. Rapid and point-of-care tests for the diagnosis of Trichomonas vaginalis in women and men. Sex Transm Infect. 2017 Dec; 93(S4): S31 - S35. doi: 10.1136/sextrans-2016-053063. Epub 2017 Jul 6.

45. Bosserman EA, Helms DJ, Mosure DJ et al Utility of antimicrobial susceptibility testing in Trichomonas vaginalis infected women with clinical treatment failure Sex Transm Dis 2011; 38: 983 - 98.

46. Levy SB, Gunta J, Edemekong P Screening for Sexually Transmitted Diseases. Prim Care. 2019 Mar; 46(1): 157 - 173. doi: 10.1016/j.pop.2018.10.013. Epub 2018 Dec 24.

47. Feng RM, Z Wang M, Smith JS et al. Risk of high-risk human papillomavirus infection and cervical precancerous lesions with past or current trichomonas infection: a pooled analysis of 25,054 women in rural China. J Clin Virol. 2018 Feb - Mar; 99 - 100: 84 - 90. doi: 10.1016/j.jcv.2017.12.015. Epub 2017 Dec 30.

48. Хрянин А.А. Решетников О.В. Клиническая и микробиологическая эффективность метронидазола и орнидазола в лечении урогенитального трихомониаза у мужчин. Издание: Антибиотики и химиотерапия. 2006 г, N 51 т1, стр 18 - 21

49. Vickovic, N., et al. Metronidazole 1.5 gram dose for 7 or 14 days in the treatment of patients with chronic prostatitis caused by Trichomonas vaginalis: A randomized study. J Chemother, 2010. 22: 364.

50. American academy of Pediatrics. Sexually Transmitted Infections. Red , editor Kimberly DW, 31st Edition, 2018, AAP Point-of-Care-Solutions. p. 821 - 823

51. А.Л. Тихомиров, Ч.Г. Олейник "Урогенитальный трихомониаз" Дерматология и венерология) Опубликовано 22-01-2010

52. А.А. Кубанова, В.И. Кисина Рациональная фармакотерапия заболеваний кожи и инфекций, передаваемых половым путем

53. Фадеев А.А., Ломоносов К.М. Выбор оптимального препарата для терапии трихомониаза Регулярные выпуски "РМЖ" N 4 от 27.02.2004

54. Рюмин Д.В., Липова Е.В., Баткаев Э.А. УРОГЕНИТАЛЬНЫЙ ТРИХОМОНИАЗ (Пособие для врачей) Москва 2001

55. Клименко, Б.В. Трихомониаз мужчин, женщин и детей/Б.В. Клименко [и др.].

56. Ю.К. Скрипкин, Ю.С. Бутов, О.Л. Иванов "Дерматовенерология. Национальное руководство" 2013.

57. Юнусова Е.И. и др. Особенности диагностики и лечения урогенитального трихомониаза//Лечащий врач. - 2014. - N. 5. - С. 47 - 47.

58. Kissinger P. et al. A randomized trial of metronidazole in a single 2 g dose versus 500 mg twice daily for 7 days for the treatment of trichomoniasis in women//The Lancet. Infectious diseases. - 2018. - T. 18. - N. 11. - C. 1251.

59. Organization Mundial de la Salud (Ginebra et al. Guidelines for the management of sexually transmitted infections. - World Health Organization, 2003.

60. Van Schalkwyk, J., Yudin, M. H., Yudin, M. H., Allen, V., Bouchard, C., Boucher, M., ... van Schalkwyk, J. (2015). Vulvovaginitis: Screening for and Management of Trichomoniasis, Vulvovaginal Candidiasis, and Bacterial Vaginosis. Journal of Obstetrics and Gynaecology Canada, 37(3), 266 - 274. doi: 10.1016/s1701-2163(15)30316-9

61. Thomason JL, Gelbart SM, Sobun JF, Schulien MB, Hamilton PR. Comparison of four methods to detect Trichomonas vaginalis. J Clin Microbiol. 1988 Sep; 26(9): 1869 - 70. doi: 10.1128/jcm.26.9.1869-1870.1988. PMID: 3141470; PMCID: PMC266735.